Study to Evaluate Diphenhydramine in Children and Adolescents
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
To characterize the pharmacokinetics of diphenhydramine in two pediatric populations:
children, ages 2 to < 12 years, and adolescents, ages 12 to < 18 years.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide